Influenza Vaccine

Novavax Inc (NASDAQ: NVAX) has announced initial results from the Phase 1/2 trial of its COVID-Influenza Combination Vaccine (CIC), combining the COVID-19 vaccine, NVX-CoV2373, and its quadrivalent influenza vaccine candidate.  The CIC trial demonstrated that the combination...

Moderna Inc (NASDAQ: MRNA) says that it's on its way to having two mRNA vaccines against different seasonal flu viruses. The Company released the first early data from Phase 1 study of mRNA-1010, announcing that all doses of the shot significantly boosted antibodies in younger...

Pfizer Inc (NYSE: PFE) has dosed the first participants in Phase 1 clinical trial to evaluate a single dose quadrivalent mRNA vaccine against influenza in healthy adults.  Also Read: Moderna Puts Its First Seasonal Flu Vaccine In The Clinic Pfizer's mRNA influenza...

The FluMist influenza vaccine doesn't work in protecting kids and adults against the flu, at least according to the Centers for Disease Control and Prevention (CDC). The CDC's Advisory Committee on Immunization Practices (ACIP) voted on Wednesday to recommend the popular nasal spray, also known as...